🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study objective: To investigate the potential anti-proteinuric and renoprot...
Status
Completed
Location
Queen Mary Hospital
Start Date
2009-07
Trial ID
NCT01150201
This clinical trial aims to evaluate the non-inferiority of Aliskiren compa...
Status
Completed
Location
Chancheng District People's Hospital, Foshan City
Start Date
2021-05-01
Trial ID
NCT06718062
Supine hypertension is a common problem that affects at least 50% of patien...
Status
Completed
Location
Vanderbilt University
Start Date
2001-01
Trial ID
NCT00223717
Treatments Being Tested
To compare the efficacy and safety of aliskiren in combination with losarta...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-10
Trial ID
NCT00219141
Treatments Being Tested
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus res...
Status
Completed
Location
University of Utah
Start Date
2020-01-19
Trial ID
NCT04467931
Treatments Being Tested
Study of the efficacy and safety of aliskiren when added to losartan and op...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2004-10
Trial ID
NCT00097955
Treatments Being Tested
This is a prospective, randomized, placebo controlled, multi-center clinica...
Status
Unknown
Location
Chulalongkorn University
Start Date
2010-07
Trial ID
NCT01305850
Treatments Being Tested
Assess if aliskiren is capable of enhancing vascular stiffness and endothel...
Status
Withdrawn
Location
Hospital Universitario Pedro Ernesto
Start Date
2011-04
Trial ID
NCT01409408
Treatments Being Tested
Assessing efficacy, safety and pharmacokinetics in patients with mild to mo...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2006-06
Trial ID
NCT00344110
Treatments Being Tested
The purpose of this study is to assess efficacy of aliskiren for reducing c...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-06
Trial ID
NCT01176032
Treatments Being Tested